These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 17664439)

  • 1. Canadian Blood Services to screen for Chagas disease.
    Comeau P
    CMAJ; 2007 Jul; 177(3):242. PubMed ID: 17664439
    [No Abstract]   [Full Text] [Related]  

  • 2. Trans-sialidase inhibition assay for the detection of Trypanosoma cruzi infection in blood donor samples from Argentina.
    Blejer JL; Sartor PA; Bottasso O; Salamone HJ; Leguizamón MS
    Vox Sang; 2008 Oct; 95(3):189-96. PubMed ID: 19121183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Post-transfusion Chagas' disease].
    Amato Neto V
    Rev Hosp Clin Fac Med Sao Paulo; 1988; 43(3):135-7. PubMed ID: 3150608
    [No Abstract]   [Full Text] [Related]  

  • 4. Knowledge deficits regarding Chagas disease may place Mexico's blood supply at risk.
    Trivedi M; Sanghavi D
    Transfus Apher Sci; 2010 Oct; 43(2):193-6. PubMed ID: 20688572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. American Red Cross to screen blood for Chagas' disease.
    McCarthy M
    Lancet; 2003 Dec; 362(9400):1988. PubMed ID: 14686364
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluating pathogen reduction of Trypanosoma cruzi with riboflavin and ultraviolet light for whole blood.
    Tonnetti L; Thorp AM; Reddy HL; Keil SD; Goodrich RP; Leiby DA
    Transfusion; 2012 Feb; 52(2):409-16. PubMed ID: 21827502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predonation testing of potential blood donors in resource-restricted settings.
    Owusu-Ofori S; Temple J; Sarkodie F; Candotti D; Allain JP
    Transfusion; 2005 Sep; 45(9):1542-3. PubMed ID: 16131391
    [No Abstract]   [Full Text] [Related]  

  • 8. Predonation testing of potential blood donors in resource-restricted settings.
    Gorlin JB
    Transfusion; 2005 Sep; 45(9):1541-2. PubMed ID: 16131390
    [No Abstract]   [Full Text] [Related]  

  • 9. Cost-effectiveness of implementation methods for ELISA serology testing of Trypanosoma cruzi in California blood banks.
    Wilson LS; Ramsey JM; Koplowicz YB; Valiente-Banuet L; Motter C; Bertozzi SM; Tobler LH
    Am J Trop Med Hyg; 2008 Jul; 79(1):53-68. PubMed ID: 18606764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chagas' disease and blood transfusion.
    Schmuñis GA
    Prog Clin Biol Res; 1985; 182():127-45. PubMed ID: 3929260
    [No Abstract]   [Full Text] [Related]  

  • 11. [Basic problems of contemporary blood donation and blood therapy].
    Sabliński J
    Acta Haematol Pol; 1995; 26(2 Suppl 1):79-85. PubMed ID: 7653238
    [No Abstract]   [Full Text] [Related]  

  • 12. Lessons learned from Trypanosoma cruzi test implementation.
    Menitove JE; Bennett JL; Sher G
    Transfusion; 2012 Sep; 52(9):1849-51. PubMed ID: 22946969
    [No Abstract]   [Full Text] [Related]  

  • 13. [Why defer blood donor candidates because of an exposure risk to Chagas disease?].
    Garraud O; Pelletier B; Aznar C
    Transfus Clin Biol; 2008 Jun; 15(3):123-8. PubMed ID: 18620885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood donor screening for chagas disease--United States, 2006-2007.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2007 Feb; 56(7):141-3. PubMed ID: 17318113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroprevalence of Trypanosoma cruzi infection in at-risk blood donors in Catalonia (Spain).
    Piron M; Vergés M; Muñoz J; Casamitjana N; Sanz S; Maymó RM; Hernández JM; Puig L; Portús M; Gascón J; Sauleda S
    Transfusion; 2008 Sep; 48(9):1862-8. PubMed ID: 18522707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Control of Chagas disease in blood banks in Colombia].
    Behrend M; Beltrán M; Restrepo M; Kroeger A
    Biomedica; 2002 Mar; 22(1):39-45. PubMed ID: 11957362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transfusion-acquired Trypanosoma cruzi infection.
    Young C; Losikoff P; Chawla A; Glasser L; Forman E
    Transfusion; 2007 Mar; 47(3):540-4. PubMed ID: 17319837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A confirmatory diagnosis of antibodies anti-Trypanosoma cruzi in donors referred by blood banks in Venezuela].
    Díaz-Bello Z; Zavala-Jaspe R; Díaz-Villalobos M; Mauriello L; Maekelt A; de Noya BA
    Invest Clin; 2008 Jun; 49(2):141-50. PubMed ID: 18717262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on seroprevalence of anti-Trypanosoma cruzi antibodies among blood donors in northeast Mexico.
    Galavíz-Silva L; Molina-Garza DP; González-Santos MA; Mercado-Hernández R; González-Galavíz JR; Rosales-Encina JL; Molina-Garza ZJ
    Am J Trop Med Hyg; 2009 Sep; 81(3):404-6. PubMed ID: 19706904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trypanosoma cruzi parasitemia in US blood donors with serologic evidence of infection.
    Leiby DA; Herron RM; Garratty G; Herwaldt BL
    J Infect Dis; 2008 Aug; 198(4):609-13. PubMed ID: 18588482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.